(Q46190958)

20 December 2017

title

Overview of topical therapy for common superficial fungal infections and the role of new topical agents (English)

1 reference

20 December 2017

author name string

Brennan B

series ordinal

1

1 reference

20 December 2017

Leyden JJ

series ordinal

2

1 reference

20 December 2017

language of work or name

English

0 references

publication date

1 February 1997

1 reference

20 December 2017

Journal of the American Academy of Dermatology

published in

1 reference

20 December 2017

volume

36

1 reference

20 December 2017

issue

2 Pt 1

1 reference

20 December 2017

page(s)

S3-8

1 reference

20 December 2017

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2970315-3

1 reference

7 January 2021

Topical antifungal drugs in the treatment of tinea pedis, tinea cruris, and tinea corporis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2970315-3

7 January 2021

Azole antifungal agents: emphasis on new triazoles

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2970315-3

7 January 2021

Synthesis and antifungal activity of butenafine hydrochloride (KP-363), a new benzylamine antifungal agent

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2970315-3

7 January 2021

Allylamine derivatives: new class of synthetic antifungal agents inhibiting fungal squalene epoxidase

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2970315-3

7 January 2021

Clinical efficacy and tolerability of terbinafine (Lamisil)--a new topical and systemic fungicidal drug for treatment of dermatomycoses

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2970315-3

7 January 2021

In-vitro studies with SF 86-327, a new orally active allylamine derivative.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2970315-3

7 January 2021

In vitro activity of terbinafine

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2970315-3

7 January 2021

Effects of butenafine hydrochloride, a new benzylamine derivative, on experimental dermatophytosis in guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2970315-3

7 January 2021

Anti-Trichophyton mentagrophytes activity and percutaneous permeation of butenafine in guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2970315-3

7 January 2021

Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2970315-3

7 January 2021

Synthesis and structure-activity correlations within allylamine antimycotics

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2970315-3

7 January 2021

Antifungal activity of the allylamine derivative terbinafine in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2970315-3

7 January 2021

Effects of squalene epoxidase inhibitors on Candida albicans

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2970315-3

7 January 2021

Topical treatment with butenafine significantly lowers relapse rate in an interdigital tinea pedis model in guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2970315-3

7 January 2021

Double-blind comparison of naftifine cream and clotrimazole/betamethasone dipropionate cream in the treatment of tinea pedis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2970315-3

7 January 2021

Topical terbinafine and clotrimazole in interdigital tinea pedis: a multicenter comparison of cure and relapse rates with 1- and 4-week treatment regimens.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2970315-3

7 January 2021

Long-term outcome of patients with interdigital tinea pedis treated with terbinafine or clotrimazole

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2970315-3

7 January 2021

One-week therapy with twice-daily butenafine 1% cream versus vehicle in the treatment of tinea pedis: a multicenter, double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2970315-3

7 January 2021

Two mechanisms of butenafine action in Candida albicans

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2897%2970315-3

7 January 2021

10.1016/S0190-9622(97)70315-3

Identifiers

DOI

1 reference

20 December 2017

1 reference

20 December 2017